Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Prelude Therapeutics Inc publishes a filing, an earnings call transcript or a press release.

Get PRLD alerts

About Peggy Scherle

The proxy statement of Prelude Therapeutics Inc reports total compensation of $819,729 for Peggy Scherle in fiscal 2025, including a base salary of $473,416. Disclosed compensation is on record for 4 fiscal years. Peggy Scherle has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Prelude Therapeutics Inc on October 20, 2026. Prelude Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Prelude Therapeutics Inc includes Krishna Vaddi (CEO and Board Member), Bryant D. Lim (CFO), Julian C. Baker (Board Member) and 3 others.

Peggy Scherle on recent calls

“So with the CAT6 biology, it's pretty clear that CAT6A is amplified in ER-positive breast cancer. And being amplified and overexpressed, it really drives the whole estrogen signaling biology as well as MYC regulation. and cell cycle genes, so it really has a strong role in driving breast cancer growth and survival.”
Other, Chardan Healthcare Conference ·
“Today, I wanted to summarize our efforts that led to the successful discovery of our first-in-class oral CAT-6A selective degrader and highlight how this is a differentiated approach to maximize the benefits of a clinically validated target in ER-positive breast cancer.”
Other, Prelude Therapeutics Inc Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Prelude Therapeutics Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Prelude Therapeutics Inc (PRLD) $473,416 $819,729
2022 Prelude Therapeutics Inc (PRLD) $416,667 $1,630,482
2021 Prelude Therapeutics Inc (PRLD) $408,271 $2,641,799
2020 Prelude Therapeutics Inc (PRLD) $347,865 $2,690,241

Recent activity